Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,598 | 58,037 | -14,863 | -11,043 | -5,972 |
| Depreciation Amortization | 626 | 2,815 | 2,144 | 1,444 | 726 |
| Accounts receivable | -1,215 | 523 | -1,835 | 11 | -803 |
| Accounts payable and accrued liabilities | -470 | N/A | -1,489 | -640 | N/A |
| Other Working Capital | -1,656 | -3,286 | -2,745 | -150 | -1,079 |
| Other Operating Activity | 1,688 | -82,373 | -1,639 | -1,389 | 707 |
| Operating Cash Flow | $-9,625 | $-24,284 | $-20,427 | $-11,767 | $-6,421 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 45 | N/A | N/A | N/A |
| PPE Investments | -251 | -461 | -460 | -332 | -99 |
| Other Investing Activity | -42 | 39,803 | -56 | -15 | 0 |
| Investing Cash Flow | $-293 | $39,387 | $-516 | $-347 | $-99 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 6,635 | 534 | 534 | N/A |
| Financing Cash Flow | $N/A | $6,635 | $534 | $534 | $N/A |
| Exchange Rate Effect | 213 | -131 | -110 | 51 | -289 |
| Beginning Cash Position | 76,374 | 54,767 | 54,767 | 54,767 | 54,767 |
| End Cash Position | 66,669 | 76,374 | 34,248 | 43,238 | 47,958 |
| Net Cash Flow | $-9,705 | $21,607 | $-20,519 | $-11,529 | $-6,809 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,625 | -24,284 | -20,427 | -11,767 | -6,421 |
| Capital Expenditure | -251 | -464 | -460 | -332 | -99 |
| Free Cash Flow | -9,876 | -24,748 | -20,887 | -12,099 | -6,520 |